Epigenetic Inhibitors: Discovery to Clinic - A Medicinal Chemist's Perspective
with Dr. Matthew Fuchter, Senior Lecturer of Synthetic and Medicinal Chemistry at the Imperial College London. NEW!
The Future of Fragments and PPIs
with Daniel A. Erlanson, Ph.D., Co-Founder, Carmot Therapeutics, Inc. and Edward R. Zartler, Ph.D., President & CSO, Quantum Tessera Consulting NEW!
View All Sponsors
Download 2015 Final Agenda